Nicolas Daniel Widjanarko, Erich Tamio, Louis Fabio Jonathan Jusni, Steven Alvianto, Erlangga Saputra Arifin, Maria Riastuti Iryaningrum
{"title":"姜黄素和胡椒碱联合补充剂对糖尿病前期和 2 型糖尿病患者血糖谱的影响:系统回顾与元分析》。","authors":"Nicolas Daniel Widjanarko, Erich Tamio, Louis Fabio Jonathan Jusni, Steven Alvianto, Erlangga Saputra Arifin, Maria Riastuti Iryaningrum","doi":"10.15605/jafes.039.01.18","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effects of the combination of curcumin and piperine supplementation on Fasting Plasma Glucose (FPG), Homeostatic Model of Insulin Resistance (HOMA-IR), and Body Mass Index (BMI) in patients with prediabetes and type 2 Diabetes Mellitus (T2DM). This review was done to identify potential herbal remedies that may help improve glycemic parameters, leading to better health outcomes in combination with current antidiabetic treatment.</p><p><strong>Methodology: </strong>This systematic review was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). It was conducted in 2023 with sources and databases from MEDLINE, EBSCO-Host, ScienceDirect and ProQuest. This paper included randomized-controlled trials exploring the effects of the combination of curcumin and piperine on patients with prediabetes and T2DM. Systematic reviews, observational studies, case reports, case series, conference abstracts, book sections, commentaries/editorials, non-human studies and articles with unavailable full-text and written in non-English language, were excluded. The key terms for the literature search were \"curcumin,\" \"piperine,\" \"prediabetes\" and \"Type 2 Diabetes Mellitus.\" We use Cochrane Risk of Bias (RoB) 2 for quality assessment of the included studies and Review Manager (RevMan) 5.4 to do the meta-analysis.</p><p><strong>Results: </strong>A total of three studies were included in this systematic review. Two studies from Neta et al., and Cicero et al., showed no significant difference in HOMA-IR, BMI and FPG levels between the curcumin, piperine and placebo groups. One study from Panahi et al. demonstrated a significant difference in BMI levels between the curcumin and piperine and placebo groups (<i>p</i> <0.01). The meta-analysis showed that FPG levels, HOMA-IR and BMI improved among patients with diabetes given in curcumin and piperine with reported mean differences (MD) of = -7.61, 95% CI [-15.26, 0.03], <i>p</i> = 0.05, MD = -0.36, 95% CI [-0.77 to 0.05], <i>p</i> = 0.09, and MD = -0.41, 95% CI [-0.85 to 0.03], <i>p</i> = 0.07, respectively).</p><p><strong>Conclusions: </strong>The supplementation of curcumin and piperine showed a numerical reduction in FPG, HOMA-IR and BMI, but were not statistically significant. Further research is needed as there is a paucity of studies included in the review.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"106-114"},"PeriodicalIF":0.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163317/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of Combination of Curcumin and Piperine Supplementation on Glycemic Profile in Patients with Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.\",\"authors\":\"Nicolas Daniel Widjanarko, Erich Tamio, Louis Fabio Jonathan Jusni, Steven Alvianto, Erlangga Saputra Arifin, Maria Riastuti Iryaningrum\",\"doi\":\"10.15605/jafes.039.01.18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aimed to evaluate the effects of the combination of curcumin and piperine supplementation on Fasting Plasma Glucose (FPG), Homeostatic Model of Insulin Resistance (HOMA-IR), and Body Mass Index (BMI) in patients with prediabetes and type 2 Diabetes Mellitus (T2DM). This review was done to identify potential herbal remedies that may help improve glycemic parameters, leading to better health outcomes in combination with current antidiabetic treatment.</p><p><strong>Methodology: </strong>This systematic review was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). It was conducted in 2023 with sources and databases from MEDLINE, EBSCO-Host, ScienceDirect and ProQuest. This paper included randomized-controlled trials exploring the effects of the combination of curcumin and piperine on patients with prediabetes and T2DM. Systematic reviews, observational studies, case reports, case series, conference abstracts, book sections, commentaries/editorials, non-human studies and articles with unavailable full-text and written in non-English language, were excluded. The key terms for the literature search were \\\"curcumin,\\\" \\\"piperine,\\\" \\\"prediabetes\\\" and \\\"Type 2 Diabetes Mellitus.\\\" We use Cochrane Risk of Bias (RoB) 2 for quality assessment of the included studies and Review Manager (RevMan) 5.4 to do the meta-analysis.</p><p><strong>Results: </strong>A total of three studies were included in this systematic review. Two studies from Neta et al., and Cicero et al., showed no significant difference in HOMA-IR, BMI and FPG levels between the curcumin, piperine and placebo groups. One study from Panahi et al. demonstrated a significant difference in BMI levels between the curcumin and piperine and placebo groups (<i>p</i> <0.01). The meta-analysis showed that FPG levels, HOMA-IR and BMI improved among patients with diabetes given in curcumin and piperine with reported mean differences (MD) of = -7.61, 95% CI [-15.26, 0.03], <i>p</i> = 0.05, MD = -0.36, 95% CI [-0.77 to 0.05], <i>p</i> = 0.09, and MD = -0.41, 95% CI [-0.85 to 0.03], <i>p</i> = 0.07, respectively).</p><p><strong>Conclusions: </strong>The supplementation of curcumin and piperine showed a numerical reduction in FPG, HOMA-IR and BMI, but were not statistically significant. Further research is needed as there is a paucity of studies included in the review.</p>\",\"PeriodicalId\":41792,\"journal\":{\"name\":\"Journal of the ASEAN Federation of Endocrine Societies\",\"volume\":\"39 1\",\"pages\":\"106-114\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163317/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the ASEAN Federation of Endocrine Societies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15605/jafes.039.01.18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the ASEAN Federation of Endocrine Societies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15605/jafes.039.01.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
研究目的本研究旨在评估姜黄素和胡椒碱联合补充剂对糖尿病前期和 2 型糖尿病(T2DM)患者空腹血浆葡萄糖(FPG)、胰岛素抵抗稳态模型(HOMA-IR)和体重指数(BMI)的影响。本综述旨在找出可能有助于改善血糖参数的潜在草药,从而与当前的抗糖尿病治疗相结合,获得更好的健康结果:本系统综述基于系统综述和元分析首选报告项目(PRISMA)。研究于 2023 年进行,研究来源和数据库包括 MEDLINE、EBSCO-Host、ScienceDirect 和 ProQuest。本文收录了探讨姜黄素和胡椒碱组合对糖尿病前期和 T2DM 患者影响的随机对照试验。系统综述、观察性研究、病例报告、系列病例、会议摘要、书籍章节、评论/编辑文章、非人类研究以及全文不可用和非英语撰写的文章均被排除在外。文献检索的关键词为 "姜黄素"、"胡椒碱"、"糖尿病前期 "和 "2 型糖尿病"。我们使用 Cochrane Risk of Bias (RoB) 2 对纳入的研究进行质量评估,并使用 Review Manager (RevMan) 5.4 进行荟萃分析:本系统综述共纳入三项研究。来自 Neta 等人和 Cicero 等人的两项研究显示,姜黄素组、胡椒碱组和安慰剂组在 HOMA-IR、BMI 和 FPG 水平上没有显著差异。Panahi等人的一项研究表明,姜黄素和胡椒碱组与安慰剂组之间的BMI水平存在显著差异(P P = 0.05,MD = -0.36,95% CI [-0.77 to 0.05],P = 0.09,MD = -0.41,95% CI [-0.85 to 0.03],P = 0.07):补充姜黄素和胡椒碱可降低 FPG、HOMA-IR 和 BMI,但在统计学上并不显著。由于综述中包含的研究较少,因此需要进一步研究。
Effects of Combination of Curcumin and Piperine Supplementation on Glycemic Profile in Patients with Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
Objective: This study aimed to evaluate the effects of the combination of curcumin and piperine supplementation on Fasting Plasma Glucose (FPG), Homeostatic Model of Insulin Resistance (HOMA-IR), and Body Mass Index (BMI) in patients with prediabetes and type 2 Diabetes Mellitus (T2DM). This review was done to identify potential herbal remedies that may help improve glycemic parameters, leading to better health outcomes in combination with current antidiabetic treatment.
Methodology: This systematic review was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). It was conducted in 2023 with sources and databases from MEDLINE, EBSCO-Host, ScienceDirect and ProQuest. This paper included randomized-controlled trials exploring the effects of the combination of curcumin and piperine on patients with prediabetes and T2DM. Systematic reviews, observational studies, case reports, case series, conference abstracts, book sections, commentaries/editorials, non-human studies and articles with unavailable full-text and written in non-English language, were excluded. The key terms for the literature search were "curcumin," "piperine," "prediabetes" and "Type 2 Diabetes Mellitus." We use Cochrane Risk of Bias (RoB) 2 for quality assessment of the included studies and Review Manager (RevMan) 5.4 to do the meta-analysis.
Results: A total of three studies were included in this systematic review. Two studies from Neta et al., and Cicero et al., showed no significant difference in HOMA-IR, BMI and FPG levels between the curcumin, piperine and placebo groups. One study from Panahi et al. demonstrated a significant difference in BMI levels between the curcumin and piperine and placebo groups (p <0.01). The meta-analysis showed that FPG levels, HOMA-IR and BMI improved among patients with diabetes given in curcumin and piperine with reported mean differences (MD) of = -7.61, 95% CI [-15.26, 0.03], p = 0.05, MD = -0.36, 95% CI [-0.77 to 0.05], p = 0.09, and MD = -0.41, 95% CI [-0.85 to 0.03], p = 0.07, respectively).
Conclusions: The supplementation of curcumin and piperine showed a numerical reduction in FPG, HOMA-IR and BMI, but were not statistically significant. Further research is needed as there is a paucity of studies included in the review.
期刊介绍:
The Journal of the ASEAN Federation of Endocrine Societies (JAFES) is an OPEN ACCESS, internationally peer-reviewed, English language, medical and health science journal that is published in print two times a year by the ASEAN Federation of Endocrine Societies. It shall serve as the endocrine window between the ASEAN region and the world, featuring original papers and publishing key findings from specialists and experts of endocrinology.